IRIS
MOSTI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.577
AS - Asia 371
SA - Sud America 56
NA - Nord America 30
AF - Africa 8
Totale 9.042
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.571
SG - Singapore 162
CN - Cina 84
VN - Vietnam 78
BR - Brasile 37
US - Stati Uniti d'America 25
HK - Hong Kong 21
AR - Argentina 14
IN - India 7
MX - Messico 5
ZA - Sudafrica 5
ID - Indonesia 4
EC - Ecuador 3
RU - Federazione Russa 3
BD - Bangladesh 2
KH - Cambogia 2
PH - Filippine 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
CG - Congo 1
CO - Colombia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
NG - Nigeria 1
PK - Pakistan 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
VE - Venezuela 1
Totale 9.042
Salva come PNG Salva come JPEG
Città #
Genova 5.535
Genoa 1.886
Rapallo 602
Vado Ligure 541
Singapore 92
Ho Chi Minh City 28
Hong Kong 21
Hanoi 18
Beijing 16
Ashburn 10
Bordighera 7
Tianjin 6
Haiphong 5
Mexico City 5
Da Nang 4
Bengaluru 3
Johannesburg 3
Mumbai 3
New York 3
São Paulo 3
Buenos Aires 2
Curitiba 2
Davao City 2
Los Angeles 2
Phnom Penh 2
Rio de Janeiro 2
Tashkent 2
Thái Nguyên 2
Zhengzhou 2
Agua de Oro 1
Alcira Gigena 1
Arroyito 1
As Sālimīyah 1
Atlanta 1
Baghdad 1
Bagé 1
Barquisimeto 1
Barra Mansa 1
Bauru 1
Belo Horizonte 1
Bijeljina 1
Biên Hòa 1
Bratislava 1
Brejo do Cruz 1
Bursa 1
Bình Dương 1
Bắc Ninh 1
Campos dos Goytacazes 1
Cao Lanh 1
Cataguases 1
Caxias do Sul 1
Cedral 1
Chapecó 1
Cixi 1
Concordia 1
Criciúma 1
Córdoba 1
Denver 1
Doha 1
Dosquebradas 1
Durban 1
Dāganbhuiya 1
Erechim 1
Formosa 1
Fortaleza 1
Foshan 1
Fourways 1
Guaratuba 1
Guayaquil 1
Hefei 1
Houston 1
Imperatriz 1
Itapevi 1
Itapira 1
Iturama 1
Jakarta 1
Jundiaí 1
Karachi 1
Khan Yunis 1
Lago Verde 1
Lagos 1
Las Toscas 1
Matinha 1
Mauá 1
Medan 1
Nairobi 1
Nha Trang 1
Nova Iguaçu 1
Nova União 1
Novokuznetsk 1
Orem 1
Osasco 1
Phúc Yên 1
Phủ Lý 1
Pointe Noire 1
Qian'an 1
Qingdao 1
Quilmes 1
Quận Ninh Kiều 1
Rosario 1
Totale 8.880
Salva come PNG Salva come JPEG
Nome #
1-Phenyl-1H-Indazole derivatives with analgesic and anti-inflammatory activities. 196
An efficient synthesis of functionalized 2-pyridones by direct route or via amide/enolate ammonium salt intermediates 193
3-Acetyl-5-acylpyridin-2(1H)-ones and 3-acetyl-7,8-dihydro-2,5(1H,6H)-quinolinediones: synthesis, cardiotonic activity and computational studies 176
4-Dialkylamino-1-(5-substituted or unsubstituted 1-phenyl-1H-pyrazol-4-yl)butan-1-ols: synthesis and evaluation of analgesic, anti-inflammatory and platelet anti-aggregating activities 174
Chemometric study and validation strategies in the structure-activity relationships of new cardiotonic agents 171
CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists. 166
Exploring the QSAR of pyrazolo[3,4-b]pyridine, pyrazolo[3,4-b]pyridone and pyrazolo[3,4-b]pyrimidine derivatives as antagonists for A1 adenosine receptor. 161
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach 161
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors 161
A chemometric approach to predict A1 agonist effect of adenosine analogues 150
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 149
2- substituted 5-acetyl-1,6-dihydro-6-oxo-3-pyridinecarboxylates: synthesis and cardiotonic activity 148
4-Substituted 1,5-diarylpyrazoles, analogues of celecoxib: synthesis and preliminary evaluation of biological properties 146
Synthesis of 5-substituted 1-aryl-1H-pyrazole-4-acetonitriles, 4-methyl-1-phenyl-1H-pyrazole-3-carbonitrile and pharmacologically active 1-aryl-1H-pyrazole-4-acetic acids. 145
4-Substituted 1-methyl-1H-indazoles with analgesic, antiinflammatory and antipyretic activities 144
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists 141
Structural basis for selective PDE 3 inhibition: a docking study 137
Synthesis and Cardiotonic Activity of Novel Pyrimidine Derivatives. Crystallographic and Quantum Chemical Studies 137
An updated topographical model for phosphodiesterase 4 (PDE4) catalytic site 136
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 136
A New Milrinone analog: Role of Binding to A1 Adenosine Receptor in its Positive Inotropic Effect on Isolated Guinea Pig and Rat Atria 133
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 131
Synthesis, molecular modeling studies and pharmacological activity of selective A1 receptor antagonists 128
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysis 126
DNA-psoralens molecular recognition using molecular dynamics 126
Unprecedented one-pot stereoselective synthesis of Knoevenagel-type derivatives via in situ condensation of N-methyleniminium salts of ethylenethiourea and ethyleneurea with active methylene reagents 125
Exploring the molecular basis of selectivity in A1 adenosine receptors antagonist: a case study 125
Ionization Behaviour and Tautomerism-Dependent Lipophilicity of Pyridine-2(1H)-one Cardiotonic Agents 121
Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site 120
New halogenated 4-aminopyrazolo[3,4-b]pyridines A1 adenosine receptor ligands 120
2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study 120
Zups: the evolution of a new class of molecular descriptors 117
null 117
Insights into Structure-Activity Relationships from Lipophilicity Profiles of Pyridin-2(1H)-one Analogs of the Cardiotonic Agent Milrinone 117
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1-H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation 116
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells 116
Synthesis and Pharmacological Characterization of Functionalized 2-Pyridones Structurally Related to the Cardiotonic Agent Milrinone 116
null 116
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 116
Structure-based Design, Parallel Synthesis, SAR and Molecular Modelling Studies of Thiocarbamates, New Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Isosteres of Phenethylthiazolylthiourea Derivatives. 115
Synthesis of indole imminun salts as key-intermediates in a convergent multi-step one-pot stereoselective synthesis of new potent antiproliferative Knoevenagel-type agent 115
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model. 115
Novel angular furo and thieno-quinolinones: synthesis and preliminary photobiological studies 110
Development of a new topographical model for myocardial cGI-PDE catalytic site 109
New pyrazolo[3,4-b]pyridones as selective A1 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies 109
Quinolinedione nucleus as a novel scaffold for A1 and A2A adenosine receptor antagonists. 109
2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study 108
Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands 107
Towards the identification of the cardiac cAMP phosphodiesterase receptor site 106
Synthesis and biological evaluation of azole derivatives, analogues of bifonazole, with a phenylisoxazolyl or phenylpyrimidinyl moiety 104
Modulazioni Strutturali in O-[2-(N-Ftalimmido)etil] Acil(Aril)Tiocarbammati, Inibitori Non-Nucleosidici della Transcrittasi Inversa di HIV-1 103
Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site 100
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines 100
null 99
New milrinone analogues:in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine and inhibition of cardiac type III phosphodiesterase 99
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and 3D-QSAR analysis 98
Reaction of Sulfene with Heterocyclic N,N-Disubstituted alfa-Amino methyleneketones.XI. Synthesis of 1,2-Oxathiino[5,6-d]-1-benzoxepin Derivatives. 98
Synthesis of pyrazolo[3,4-d]pyridines selective antagonists of A1 adenosine receptors 97
Androstane derivatives: synthesis of substituted 6'-H-androst-2-eno*3,2-b*pyran-6'-ones. 97
Reaction of Sulfene with Heterocyclic N, N-Disubstituted alfa-Amino methyleneketones. IX. Synthesis of 1,2-Oxathiino [6,5-e] indole Derivatives. 97
null 95
Riconoscimento molecolare DNA-psoraleni mediante tecniche di dinamica molecolare 94
In silico rationalization of the structural and physicochemical requirements for photobiological activity in angelicine derivatives and their heteroanalogues 94
Molecular Modeling of DNA-psoralens complexes 93
QSAR study on new cardiotonic agents related to milrinone 92
Synthesis, Biological Evaluation and Molecular Modeling Studies on Benzothiadiazine Derivatives as PDE4 Selective Inhibitors 87
Flavonoidverbindungen und Allantoin aus Anchusa officinalis L. 86
Synthesis, antimicrobial activity and molecular modelling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles 81
New pyrazolo[3,4-b]pyridines antagonist of A1 adenosine receptors 80
Inotropic Agents. Synthesis and Structure-Activity Relationships of New Milrinone Related cAMP PDEIII inhibitors 80
Glycoside und Depside aus den Blättern von Castanea sativa Mill. 80
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitors 77
omega-Dialkylaminoalkil Ethers of Phenyl-(5-substituted 1-phenyl-1H-pyrazol-4-yl)methanols with Analgesic and Anti-inflammatory Activity 76
Studio computazionale di complessi di intercalazione al buio DNA-psoraleni Pavia, 27-29 maggio 1999 73
Synthesis and photobiological properties of 3-acylangelicins, 3-alkoxycarbonyl-angelicins and related derivatives 70
Zupan's descriptors in QSAR applied to the study of a new class of cardiotonic agents 68
Synthesis of new pyrazolo[3,4-b]pyridines: new selective A1 adenosine receptor antagonists 62
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses 58
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses 27
Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant 21
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actions 16
Totale 9.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.953
article - articoli 23.072
book - libri 0
conference - conferenze 4.881
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 22 17 30 37 38 26 43
2021/2022949 43 85 70 91 26 43 63 254 39 85 45 105
2022/2023730 66 47 7 85 122 121 0 37 104 5 117 19
2023/2024361 20 59 11 51 38 51 20 15 9 12 35 40
2024/20251.322 24 91 40 105 189 130 99 248 72 62 131 131
2025/20261.111 285 58 167 194 363 44 0 0 0 0 0 0
Totale 9.139